Recombinant multi-species BCL10 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine BCL10 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene was identified by its translocation in a case of mucosa-associated lymphoid tissue (MALT) lymphoma. The protein encoded by this gene contains a caspase recruitment domain (CARD), and has been shown to induce apoptosis and to activate NF-kappaB. This protein is reported to interact with other CARD domain containing proteins including CARD9, 10, 11 and 14, which are thought to function as upstream regulators in NF-kappaB signaling. This protein is found to form a complex with MALT1, a protein encoded by another gene known to be translocated in MALT lymphoma. MALT1 and this protein are thought to synergize in the activation of NF-kappaB, and the deregulation of either of them may contribute to the same pathogenetic process that leads to the malignancy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]
The Alternative Names of target: B-cell CLL/lymphoma 10 (Bcl-10),B-cell lymphoma/leukemia 10,BCL-10,BCL10,Bcl10,CARD-containing molecule enhancing NF-kappa-B,CARD-like apoptotic protein (hCLAP),CARMEN,CED-3/ICH-1 prodomain homologous E10-like regulator (CIPER),CIPER,CLAP,Cellular homolog of vCARMEN (cCARMEN),Cellular-E10 (c-E10),IMD37,ME10,Mammalian CARD-containing adapter molecule E10 (mE10),c-E10,cE10,mE10

Target products collectionGo to BCL10 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP13325-Ag-1/ GM-Tg-hg-IP13325-Ag-2 Human BCL10 protein Human
GM-Tg-rg-IP13325-Ag-1/ GM-Tg-rg-IP13325-Ag-2 Rat BCL10 protein Rat
GM-Tg-mg-IP13325-Ag-1/ GM-Tg-mg-IP13325-Ag-2 Mouse BCL10 protein Mouse
GM-Tg-cynog-IP13325-Ag-1/ GM-Tg-cynog-IP13325-Ag-2 Cynomolgus/Rhesus macaque BCL10 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP13325-Ag-1/ GM-Tg-felg-IP13325-Ag-2 Feline BCL10 protein Feline
GM-Tg-cang-IP13325-Ag-1/ GM-Tg-cang-IP13325-Ag-2 Canine BCL10 protein Canine
GM-Tg-bovg-IP13325-Ag-1/ GM-Tg-bovg-IP13325-Ag-2 Bovine BCL10 protein Bovine
GM-Tg-equg-IP13325-Ag-1/ GM-Tg-equg-IP13325-Ag-2 Equine BCL10 protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP13325-Ag-1/ GM-Tg-hg-IP13325-Ag-2; GM-Tg-rg-IP13325-Ag-1/ GM-Tg-rg-IP13325-Ag-2;
GM-Tg-mg-IP13325-Ag-1/ GM-Tg-mg-IP13325-Ag-2; GM-Tg-cynog-IP13325-Ag-1/ GM-Tg-cynog-IP13325-Ag-2;
GM-Tg-felg-IP13325-Ag-1/ GM-Tg-felg-IP13325-Ag-2; GM-Tg-cang-IP13325-Ag-1/ GM-Tg-cang-IP13325-Ag-2;
GM-Tg-bovg-IP13325-Ag-1/ GM-Tg-bovg-IP13325-Ag-2; GM-Tg-equg-IP13325-Ag-1/ GM-Tg-equg-IP13325-Ag-2
Products Name BCL10 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name BCL10
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine BCL10 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.